These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29863114)

  • 21. Effectiveness of polymyxin B-immobilized hemoperfusion against sepsis and septic shock: A systematic review and meta-analysis.
    Li X; Liu C; Mao Z; Qi S; Song R; Zhou F
    J Crit Care; 2021 Jun; 63():187-195. PubMed ID: 33012579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection.
    Vincent JL; Laterre PF; Cohen J; Burchardi H; Bruining H; Lerma FA; Wittebole X; De Backer D; Brett S; Marzo D; Nakamura H; John S
    Shock; 2005 May; 23(5):400-5. PubMed ID: 15834304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A longer duration of polymyxin B-immobilized fiber column hemoperfusion improves pulmonary oxygenation in patients with septic shock.
    Mitaka C; Tsuchida N; Kawada K; Nakajima Y; Imai T; Sasaki S
    Shock; 2009 Nov; 32(5):478-83. PubMed ID: 19295483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unsatisfactory Short-Term Neurodevelopmental Outcomes of Preterm Infants Who Received Polymyxin B-Immobilized Fiber Column-Direct Hemoperfusion for Septic Shock.
    Nishizaki N; Shima T; Watanabe A; Obinata K; Shimizu T
    Tohoku J Exp Med; 2021 Apr; 253(4):275-281. PubMed ID: 33896891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and Safety of Direct Hemoperfusion Using Polymyxin B-Immobilized Polystyrene Column for Patients With COVID-19: Protocol for an Exploratory Study.
    Terada-Hirashima J; Izumi S; Katagiri D; Uemura Y; Mikami A; Sugiura W; Abe S; Azuma A; Sugiyama H
    JMIR Res Protoc; 2022 Nov; 11(11):e37426. PubMed ID: 36126219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection.
    Saito N; Sugiyama K; Ohnuma T; Kanemura T; Nasu M; Yoshidomi Y; Tsujimoto Y; Adachi H; Koami H; Tochiki A; Hori K; Wagatsuma Y; Matsumoto H
    PLoS One; 2017; 12(3):e0173633. PubMed ID: 28358803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of early start of direct hemoperfusion with polymyxin B-immobilized fiber columns judging from stabilization in circulatory dynamics in surgical treatment patients.
    Sakamoto Y; Mashiko K; Obata T; Matsumoto H; Hara Y; Kutsukata N; Yokota H
    Indian J Crit Care Med; 2010 Jan; 14(1):35-9. PubMed ID: 20606907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The severity of hyperdynamic circulation may predict the effects of direct hemoperfusion with the adsorbent column using polymyxin B-immobilized fiber in patients with gram-negative septic shock.
    Uriu K; Osajima A; Kamochi M; Watanabe H; Aibara K; Kaizu K
    Ther Apher; 2001 Feb; 5(1):25-30. PubMed ID: 11258606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. pH after the first session of direct hemoperfusion with polymyxin B-immobilized fibers predicts mortality in patients with sepsis and septic shock.
    Okubo A; Nakashima A; Doi S; Ueno T; Sasaki K; Esaki T; Masaki T
    Clin Exp Nephrol; 2018 Oct; 22(5):1167-1173. PubMed ID: 29478200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis.
    Fujii T; Ganeko R; Kataoka Y; Furukawa TA; Featherstone R; Doi K; Vincent JL; Pasero D; Robert R; Ronco C; Bagshaw SM
    Intensive Care Med; 2018 Feb; 44(2):167-178. PubMed ID: 29204670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymyxin B hemoperfusion as a feasible therapy after source control in abdominal septic shock.
    Kim JJ; Park YJ; Moon KY; Park JH; Jeong YK; Kim EY
    World J Gastrointest Surg; 2019 Dec; 11(12):422-432. PubMed ID: 31879534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Polymyxin-B direct hemoperfusion (PMX-DHP) in gram negative sepsis].
    Perego AF; Morabito S; Graziani G; Casella GP; Parodi O
    G Ital Nefrol; 2006; 23 Suppl 36():S94-102. PubMed ID: 17068736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymyxin B-immobilized fiber column hemoperfusion mainly helps to constrict peripheral blood vessels in treatment for septic shock.
    Sugiura M; Mitaka C; Haraguchi G; Tomita M; Inase N
    J Intensive Care; 2015; 3(1):14. PubMed ID: 25866644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical significance of serum procalcitonin levels following direct hemoperfusion with polymyxin B-immobilized fiber column in septic patients with colorectal perforation.
    Shimizu T; Hanasawa K; Sato K; Umeki M; Koga N; Naganuma T; Sato S; Shimonishi T; Ikeda T; Matsuno N; Ono S; Saitoh H; Satoh K; Otani Y; Endo Y; Eguchi Y; Tani T;
    Eur Surg Res; 2009; 42(2):109-17. PubMed ID: 19122457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early induction of direct hemoperfusion with a polymyxin-B immobilized column is associated with amelioration of hemodynamic derangement and mortality in patients with septic shock.
    Chihara S; Masuda Y; Tatsumi H; Nakano K; Shimada T; Murohashi T; Yamakage M
    J Artif Organs; 2017 Mar; 20(1):71-75. PubMed ID: 27469940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber.
    Aoki H; Kodama M; Tani T; Hanasawa K
    Am J Surg; 1994 Apr; 167(4):412-7. PubMed ID: 8179086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiopoietin Balance in Septic Shock Patients With Acute Kidney Injury: Effects of Direct Hemoperfusion With Polymyxin B-Immobilized Fiber.
    Ebihara I; Hirayama K; Nagai M; Shiina E; Koda M; Gunji M; Okubo Y; Sato C; Usui J; Yamagata K; Kobayashi M
    Ther Apher Dial; 2016 Aug; 20(4):368-75. PubMed ID: 27523077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial.
    Klein DJ; Foster D; Walker PM; Bagshaw SM; Mekonnen H; Antonelli M
    Intensive Care Med; 2018 Dec; 44(12):2205-2212. PubMed ID: 30470853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber.
    Ono S; Tsujimoto H; Matsumoto A; Ikuta S; Kinoshita M; Mochizuki H
    Am J Surg; 2004 Aug; 188(2):150-6. PubMed ID: 15249240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymyxin B Hemoperfusion for Sepsis and Septic Shock: A Systematic Review and Meta-Analysis.
    Terayama T; Yamakawa K; Umemura Y; Aihara M; Fujimi S
    Surg Infect (Larchmt); 2017 Apr; 18(3):225-233. PubMed ID: 28092497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.